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Summary
Objectives: Although well-defined principles of rational antimicrobial use are available, inap-
propriate prescribing patterns are reported worldwide. Accurate information on the usage of
antimicrobials, including factors associated with and influencing their use, is valuable for
improving the quality of prescription practices.
Methods: In this cross-sectional point prevalence survey, data on patients hospitalized in 12
different children’s hospitals were collected on a single day. Appropriateness of prescription
was compared between the types of antimicrobials prescribed, indications, wards, and presence
of/consultation with an infectious disease physician (IDP).
* Corresponding author. Tel.: +90 312 311 4963; fax: +90 312 310 8241.
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Results: A total 711 of 1302 (54.6%) patients evaluated were receiving one or more antimicrobial
drugs. The antimicrobial prescription rate was highest in pediatric intensive care (75.7%) and
lowest in the surgery wards (37.0%). Of the 711 patients receiving antimicrobials, 332 patients
(46.7%) were found to be receiving at least one inappropriately prescribed drug. Inappropriate
use was most frequent in surgery wards (80.2%), while it was less common in oncology wards
(31.8%; p < 0.001). Respiratory tract infection was themost common indication for antimicrobial
use (29.4%). Inappropriate use was more common in deep-seated infections (54.7%) and respira-
tory infections (56.5%). Fluoroquinolones were used inappropriately more than any other drugs
(81.8%, p = 0.021). Consultation with an IDP appears to increase appropriate antimicrobial use
( p = 0.008).
Conclusions: Inappropriate antimicrobial use remains a common problem in Turkish pediatric
hospitals. Consultation with an IDP and prescribing antimicrobial drugs according to micro-
biological test results could decrease the inappropriate use of antimicrobials.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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While antimicrobial drugs are responsible for some of the
most dramatic improvements in medical therapy in history,
these medicines are also the only class of drug whose efficacy
diminishes with their wide-scale use in hospital-based and
outpatient settings. The increased use of antimicrobial drugs
has coincided with the emergence of antimicrobial resis-
tance, which constitutes an important clinical, economic,
and public health problem.1—3 Resistant pathogens increase
healthcare associated expense, complicate therapy, and
make treatment failure more likely. Therefore, there has
been a growing attentiveness to the rational use of antimi-
crobials since the 1990s.4
Although the number of prescriptions for antibiotics for
children decreased during the 1990s, the use of broad-
spectrum antibiotics increased at the same time.5,6 The
overuse of expensive broad-spectrum intravenous (IV)
agents and the ecological impact of prescribed drugs on
the hospital microflora have contributed to high levels of
expenditure in healthcare management.7—9 The indirect
costs of IV therapy include preparation, administration,
and monitoring of injections or infusions, which also affect
nursing, medical, and/or pharmacy time. Surveying anti-
biotic prescribing in hospitals is important to detect
the current situation and for policy-making to change
incorrect practices. Continuous surveillance may be time-
consuming and expensive. However, point prevalence stu-
dies of antibiotic prescribing provide a useful insight into
patterns of prescribing, potentially reporting a more
focused audit on specific agents or specialties.10 Such
surveys may point to changes in prescribing practices within
the same hospital over time or indeed highlight differences
between hospitals.
Point prevalence studies have been increasingly under-
taken in adult hospitals in many countries including Tur-
key.11,12 However, there is no information on the use of
antimicrobials for children in our country, and data are very
limited worldwide. Therefore, we performed this cross-sec-
tional national point prevalence survey in patients hospita-
lized in children’s hospitals to determine the prevalence of
inappropriate antimicrobial use and factors associated with
and influencing this.Materials and methods
After obtaining ethical approval from the local ethics boards
of all the participating centers and the Central Ethical
Committee of the Ministry of Health, a questionnaire was
developed by the Turkish Collaborative Study Group on Hos-
pital Infections and sent to the study centers. Twelve pedia-
tric hospitals in nine cities located in all of the seven
geographic regions of Turkey were selected to represent
the population characteristics of the country. Two centers
from each of the three largest cities and one center from
each of the other cities were included. Each health center
serves as a referral center for its region in the field of
pediatric diseases. The centers serve approximately 32% of
the entire pediatric population of Turkey.
Data on diagnosis, demographics, antimicrobials given to
the patients, dosage, indications, microbiological test
results, existence of pediatric infectious disease specialist
in the center, and presence of pediatric infectious disease
physician consultation for all pediatric patients (aged 0—16
years) hospitalized in intensive care units, neonatal intensive
care units, pediatric wards (including special infectious dis-
eases and oncology wards) or surgical wards were collected
by pediatricians and infection control nurses on October 3,
2007. All patients who were receiving antimicrobials for any
reason were included in the study. Lists of patients were
obtained between 8:00 a.m. and 9:00 a.m. on the day that
the surveillance was conducted. Wards were surveyed over a
10-hour period starting at 9:00 a.m. and finishing at 9:00 p.m.
on the same day. Children admitted or prescribed new
antibiotics after 9:00 p.m. were not included. Data were
collected from chart review, discussions with nursing staff,
and laboratory records. Data were collected on manually
completed forms and forwarded to the Department of Pedia-
tric Infectious Diseases, Medical School, Hacettepe Univer-
sity for data entry and analysis. The records were evaluated
by the principal investigator together with two other pedia-
tric infectious disease specialists from the study group.
Antimicrobial drug use was considered inappropriate if
indication and choice of the drug(s) or dose of the antimi-
crobials were wrong. Information in the guidelines of the
American Academy of Pediatrics and classical textbooks was
used in this evaluation.13,14 Indication and dosage errors
Table 1 Rate of antibiotic use in different pediatric wards
Ward Number of patients
ordered antibiotics
Total hospitalized
patients
Percentage
antibiotic prescription
p-Value
Intensive care 89 119 74.8 0.033
PICU 56 74 75.7 0.074
NICU 33 45 73.3 0.206
Pediatrics 541 964 56.1 0.701
Infectious diseases 66 80 82.5 0.016
Other 475 884 53.7 0.826
Surgery 81 219 37.0 <0.001
Total a 711 1302 54.6
PICU, pediatric intensive care unit; NICU, neonatal intensive care unit.
a Chi-square 73.6, degrees of freedom 2, p < 0.001.
Table 2 Antimicrobials prescribed to hospitalized patients
Antimicrobial Number
of patients
Percentage
Cephalosporins 291 22.1
1st generation 13 1.0
2nd generation 15 1.1
3rd generation 219 16.6
4th generation 44 3.3
Penicillins 270 20.5
Narrow- and broad-spectrum 136 10.3
Combinations with b-lactamase
inhibitors
134 10.2
Aminoglycosides 218 16.6
Glycopeptides 134 10.2
Carbapenems 150 11.4
Metronidazole 44 3.3
Macrolides 28 2.1
Clindamycin 20 1.5
Fluoroquinolones 11 0.8
Trimethoprim/sulfamethoxazole 13 1.0
Chloramphenicol 6 0.5
Linezolid 5 0.4
Antifungals 88 6.7
Fluconazole 41 3.1
Amphotericin B 42 3.2
Caspofungin 5 0.4
Antivirals 24 1.8
Acyclovir 21 1.6
Ganciclovir 3 0.2
Antituberculous 15 1.1
Total 1317 100
Note: Some patients were ordered more than one antimicrobial.
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quency of such errors and the presence of an infectious
diseases specialist in the center, infectious disease physician
consultation, antibiotic chosen, indication, and hospital
wards were assessed.
After excluding unavailable patients, all analyses were
performed using SPSS version 11.5 (SPSS Inc., Chicago, IL,
USA). The significance of differences between groups was
evaluated using the Chi-square test with correction when
appropriate and t-tests as indicated.
Results
A total of 1302 pediatric patients were surveyed in 12
hospitals. Three of the centers were stand-alone pediatric
hospitals and the other nine centers were university-
affiliated pediatric hospitals, which were part of combined
adult—pediatric hospitals. Of the patients studied, most
were hospitalized in Hacettepe University (16.6%) and the
least number of patients were from Gaziantep University
Medical Center (3.5%); the distribution of the patients was
comparable with the hospital bed capacity and population
served.
Of the 1302 patients surveyed, 711 (54.6%) were receiving
antimicrobial drugs. The mean age of patients receiving
antimicrobials was 49.51 (57.78) months. In those partici-
pating in the survey, 578 (44.4%) were female and 724 (55.6%)
were male. One hundred nineteen (9.1%) patients were in
intensive care units (45 (3.5%) were in neonatal intensive
care units), 80 (6.1%) were in infectious diseases wards, 884
(67.9%) were in pediatric wards (125 (9.6%) in oncology
wards), and 219 (16.8%) were in surgery wards.
Among patients receiving antimicrobials, 283 (39.8%)
were receiving one drug, 304 (42.8%) two drugs, 86
(12.1%) three drugs, 25 (3.5%) four drugs, 10 (1.4%) five
drugs, and 3 (0.4%) six different drugs.
The most common indication for antimicrobial therapy
was respiratory tract infection (RTI; 209 patients, 29.4%).
This was followed by empirical therapy in 133 (18.7%)
patients, deep-seated infection (DSI; endocarditis, central
nervous system infections, etc.) in 75 (10.5%), blood stream
infection (BSI; sepsis, bacteremia, etc.) in 69 (9.7%), urinary
tract infection (UTI) in 59 (8.3%), intra-abdominal infection
in 43 (6.0%), skin and soft tissue infection (SSTI) in 31 (4.4%),
and other infection in 36 (5.1%). The indication was not
documented in 56 (7.9%) patients.The highest antimicrobial consumption rate was found in
intensive care and the infectious diseases wards; patients
hospitalized in the surgery wards were least likely to undergo
antimicrobial treatment. The antimicrobial prescription rate
was 75.7% in pediatric intensive care, 73.3% in neonatal
intensive care, 82.5% in the infectious diseases wards,
53.7% in the general pediatric wards, and 37.0% in the surgery
wards (Table 1).
The most commonly used antimicrobial agents were
cephalosporins (291 patients, 22.1%) and penicillins (270
Table 3 Inappropriate antibiotic usage according to indication and microbiological test results
Indication Patients receiving
antibiotics
Antimicrobials given according to microbiological test results a
Number Percent Number Antimicrobials ordered Percent p-Value
Respiratory infection 209 29.4 17 375 4.5 0.002
Empirical b 133 18.7 0 259 0
Deep-seated infectionc 75 10.5 24 135 17.8 0.018
Blood stream infectiond 69 9.7 26 148 17.6 0.017
Urinary tract infection 59 8.3 32 75 42.7 <0.001
Intra-abdominal infection 43 6.0 13 101 12.9 0.445
Skin and soft tissue infection 31 4.4 9 54 16.7 0.180
Other 36 5.1 6 75 8 0.579
Undocumented 56 7.9 8 95 8.4 0.617
Total e 711 100 135 1317 10.2
a Microbiological tests: culture, serology, PCR, etc.
b For febrile neutropenia, premature newborns with early membrane rupture, etc.
c Endocarditis, central nervous system infection, etc.
d Sepsis, bacteremia.
e Chi-square 63.5, degrees of freedom 7, p < 0.001.
e58 M. Ceyhan et al.patients, 20.5%) (Table 2). The rate of prescribing antimi-
crobials according to microbiological test results was lowest
in RTIs (4.5%, p = 0.002) and highest in UTIs (42.7%,
p < 0.001) (Table 3). Although the frequency of using anti-
microbials depending on the test results was lower than that
in RTIs, the rate of usage according to microbiological test
results was statistically higher in DSIs (17.8%, p = 0.018) and
BSIs (17.6%, p = 0.017) than for the other indications.
Out of 711 patients receiving antimicrobials, 332 patients
(46.7%) were found to be receiving at least one inappropri-
ately prescribed drug. Fluoroquinolones were used in 11Table 4 Comparison of the 11 most commonly used antibacteria
Antibiotic Numbers of antibiotics
Inappropriate
indication
Inappropria
dosage
Cephalosporins 102 8
1st generation 1 0
2nd generation 5 0
3rd generation 82 7
4th generation 14 1
Penicillins 113 14
Narrow- and broad-spectrum 53 6
Combinations with b-lactamase
inhibitors
60 8
Aminoglycosides 82 9
Carbapenems 58 2
Glycopeptides 39 5
Metronidazole 11 0
Macrolides 18 0
Clindamycin 7 1
Trimethoprim/sulfamethoxazole 6 2
Fluoroquinolones 8 2
Total a 444 43
a Chi-square 27.1, degrees of freedom 10, p = 0.005.patients and caspofungin in five in spite of their limited
indications. We determined that fluoroquinolones were the
most inappropriately used antibiotics (81.8%, p = 0.021);
first-generation cephalosporins (7.7%), glycopeptides
(31.3%), metronidazole (25%), and clindamycin (28%) were
used more appropriately than the others ( p = 0.005, 0.001,
and 0.005, respectively) (Table 4).
The presence of a pediatric infectious disease specialist in
the center did not affect the rate of inappropriate antimi-
crobial use ( p > 0.05), however, patient consultation with an
infectious disease physician was found to be related to al drugs for inappropriate indication and/or dosage use
Percentage of
inappropriately
used antibiotics
p-Value
te Inappropriate
indication
and/or dosage
Used in
total
105 291 36.1 0.547
1 13 7.7 0.005
5 15 33.3 0.765
85 219 38.8 0.982
14 44 31.8 0.050
118 270 43.7 0.348
55 136 40.4 0.822
63 134 47.0 0.245
87 218 39.9 0.858
58 150 38.7 0.966
42 134 31.3 0.001
11 44 25 0.005
18 28 64.3 0.068
7 25 28 0.005
6 13 46.2 0.732
9 11 81.8 0.021
461 1184 39.9 0.005
Table 5 Evaluation of inappropriate antimicrobial drug use by pediatric infectious disease consultation, hospital ward, and
indication
Number of patients with: Percentage of
inappropriate
use
Chi-square, degrees
of freedom, p-value
Inappropriate
indication
Inappropriate
dosage
Inappropriate
indication
and/or dosagea
Antimicrobial
treatment
Pediatric infectious disease specialist at the center
Absent 182 42 215 461 46.6 0.01, DF 1, p = 0.980
Present 118 7 117 250 46.8
Pediatric infectious disease consultation
Absent 247 36 265 552 48.0 7.36, DF 1, p = 0.008
Present 53 13 57 159 35.8
Wards
Intensive care unit 28 5 28 56 50 46.71, DF 4, p < 0.001
Neonatal intensive
care unit
17 1 17 33 51.5
Oncology 21 3 21 66 31.8
Pediatrics 175 29 201 475 42.3
Surgery 59 11 65 81 80.2
Indication
Respiratory
infection
112 26 118 209 56.5 23.91, DF 8, p = 0.006
Deep-seated
infectionb
39 6 41 75 54.7
Blood stream
infectionc
25 4 26 69 37.7
Urinary tract
infection
13 5 16 59 27.1
Intra-abdominal
infection
17 6 20 43 46.5
Skin and soft
tissue infection
6 10 10 31 32.3
Empirical d 55 5 56 133 42.1
Undocumented 22 2 22 56 39.3
Other 17 2 17 36 47.2
Total 306 66 326 711 45.9
a Some patients were ordered antimicrobials both with the wrong indication and dosage.
b Endocarditis, central nervous system infections, etc.
c Sepsis, bacteremia.
d For febrile neutropenia, premature newborns with early membrane rupture, etc.
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highest rate of inappropriate antimicrobial use was observed
in surgery units (80.2%), while in contrast, inappropriate
prescription was found less frequently in the oncology wards
(31.8%; p <0.001). When we look at the indications for
antimicrobial treatment, antimicrobials were most appro-
priately used in UTI patients (72.9%, p = 0.006).
Discussion
The appropriate use of antimicrobials plays a key role in
efforts aimed at establishing a good and cost-effective
healthcare system in pediatric hospitals. The observation
of an increasing antibacterial resistance in Turkish hospi-
tals11,12,15 prompted this survey of inappropriate use of
antibacterial drugs in the Turkish pediatric population.
Because our study centers provide a service to approximately
32% of the pediatric population of Turkey, we believe that ourresults may be used to give a general view of the situation in
Turkish pediatric hospitals.
In a multicenter study undertaken in adult hospitals in
Turkey, the frequency of antimicrobial prescription was
found to be 30.6% in hospitalized patients.11 In our study,
54.6% of patients were receiving antimicrobial treatment,
and it seems that pediatric patients are receiving antimicro-
bials more frequently than adult patients in hospitals in
Turkey. This frequency is similar to those reported from
developing countries, such as 77.8% in China and 65.0% in
Costa Rica.16,17 Although the antimicrobial prescription rate
was found to be higher in adult surgical wards compared to
other adult hospital wards in Turkey and also in Germany as a
developed country,11,18 surgery wards had the lowest rate of
antibiotic use in our study (37.0%, p < 0.001). This may be
related to the types of surgical operations in pediatric
patients, which have a lower requirement for prophylactic
and empirical antimicrobial therapy. In the present study, the
e60 M. Ceyhan et al.higher rates of antimicrobial treatment in the infectious
diseases wards (82.5%, p = 0.016) and the pediatric and
neonatal ICUs (in spite of the lack of statistical significance;
75.7%, p = 0.074 and 73.3%, p = 0.206, respectively), may be
not surprising; however we believe that these rates are far
outside the acceptable range when compared to reported
prescription frequencies of 6.55% and 14.4% from two dif-
ferent pediatric ICUs in Israel and some other studies in
recent years.19
We found that the empirical use of antimicrobial drugs was
the secondmost common indication for therapy after respira-
tory infections, and this is comparable to results found in the
literature.20 The high rate of empirical therapy is possibly
related to the low positive results of microbiological tests,
which especially for culture constitutes a vicious circle, as
higher and previous antimicrobial use will affect the sensi-
tivity of these tests.
The unnecessary use of antimicrobial drugs has been
reported as 14% to 43% in hospitalized patients.11,15 We
calculated unnecessary use in the inappropriate usage rate,
however if we believe that unnecessary therapy is the most
frequent error in antimicrobial prescriptions, it can be con-
cluded that unnecessary antimicrobial use in our pediatric
patients is more common than in previous reports. Errors in
therapy were noted in 30% of the medical orders and 63% of
the surgical orders.
Our study showed that only 21.5% of the surveyed patients
were receiving one antimicrobial, whereas combination ther-
apy was given to 33% of the patients. This is comparable to
the results of a study in adults in Turkey and the general
literature.11,12 This high proportion of combination therapy
may be related to the prescription of empirical treatment
without the support of microbiological test results in order to
increase the spectrum of action.
Although the presence of a pediatric infectious disease
specialist in the center did not affect the rate of inappropri-
ate use of antimicrobials, consultation with a specialist did
decrease inappropriate use significantly ( p = 0.008). To the
best of our knowledge, this is the first study evaluating this
factor, and consulting with patients to determine whether
they need antimicrobial treatment can decrease the rate of
unnecessary antimicrobial prescription. Although it is diffi-
cult to explain the similar rates of inappropriate antimicro-
bial usage in the centers that had infectious disease
physicians and in the centers that did not, low consultation
rates in the latter may be a reason.
Although the rate of antimicrobial drug use was lowest in
the surgical wards, inappropriate use was most common in
these services (80.2%, p < 0.001). The high rate of prophy-
lactic antimicrobial use may be the cause of this inappropri-
ate treatment.7,17 On the other hand, oncology wards had the
lowest rate of inappropriate antimicrobial treatment. This is
probably as a result of the more frequent consultation of
oncology patients with infectious disease departments
because of their underlying high-risk diseases. Antimicrobial
drugs were used more appropriately in patients with UTIs
(27.1%, p = 0.006) than the other infections. The presence of
more microbiological evidence in UTIs (42.7%, p < 0.001)
than in the other infections may be thought of as the reason
for this. These results show the importance of collaboration
among the departments of infectious diseases, microbiology,
infection control, general pediatrics, oncology, and surgery.In the pediatric patients, the most commonly used anti-
microbialswere thepenicillins andcephalosporins,ashasbeen
found in adult cases.9,11 However, fluoroquinolones were the
drugs most commonly used inappropriately. This is related to
the use of these antibiotics despite the limited approved
indications, and may be a cause of the fact that bacterial
resistance against b-lactams and quinolones has increased
significantly in Turkey in recent years; fluoroquinolone resis-
tance has reached up to 40% in invasive E. coli isolates.21
Plasmid-mediated quinolone resistance in particular has been
thought of as responsible for the emerging problem in
extended-spectrum b-lactamase (ESBL)-positive Enterobac-
teriaceae in our region.22 High-level fluoroquinolone resis-
tance has also been reported in Streptococcus pneumoniae
in Turkey.23
On the other hand, glycopeptides, clindamycin, and
metronidazole were the antibiotics that were most appro-
priately used. The rare indications for their use, being the
second or third choice of drug, with these antibiotics usually
used after treatment with first-choice antimicrobials such as
penicillins, cephalosporins, and aminoglycosides, and infec-
tious disease consultation are probably the reasons for their
appropriate use.
In conclusion, there is the need for microbiological sup-
port for clinicians to increase the rate of appropriate pre-
scription. Increasing the number of pediatric infectious
disease specialists, practical antimicrobial treatment guide-
lines, and continuing education for general pediatricians,
oncologists, and surgeons are also important to resolve the
problem of inappropriate antimicrobial use. Although con-
tinuous surveillance using hospital pharmacy data is available
in many developed countries, point prevalence studies
are advantageous because they may be more feasible in
those countries lacking automated systems. These studies
must be done repeatedly and the results of these surveys
should be used in formulating the antimicrobial treatment
policies in the pediatric hospitals.
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